Therefore, the investigation of HERV-K (HML-2) as a potential drug target and the development of antivirals for viral infections and cancer treatment offer promising therapeutic opportunities that hold the potential to revolutionize the field of medicine. This evidence concerns the gene CLEC10A and cancer.